UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 170 filers reported holding UNIQURE NV in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $25,683,000 | +102.4% | 1,369,032 | +101.1% | 0.16% | +113.0% |
| Q2 2022 | $12,687,000 | +96.3% | 680,653 | +118.4% | 0.08% | +126.5% |
| Q4 2021 | $6,463,000 | -78.8% | 311,600 | -67.3% | 0.03% | -79.4% |
| Q3 2021 | $30,489,000 | +15.9% | 952,478 | +11.6% | 0.16% | +10.7% |
| Q2 2021 | $26,297,000 | -18.1% | 853,813 | -10.4% | 0.15% | -26.2% |
| Q1 2021 | $32,105,000 | +15.4% | 952,928 | +23.7% | 0.20% | +14.8% |
| Q4 2020 | $27,824,000 | +7.9% | 770,120 | +10.0% | 0.18% | -10.7% |
| Q3 2020 | $25,797,000 | -39.0% | 700,426 | -25.3% | 0.20% | -46.9% |
| Q2 2020 | $42,273,000 | -8.8% | 938,130 | -4.0% | 0.37% | -25.4% |
| Q1 2020 | $46,369,000 | +85.3% | 977,206 | +179.8% | 0.50% | +121.9% |
| Q4 2019 | $25,024,000 | +187.2% | 349,205 | +57.8% | 0.22% | +148.9% |
| Q3 2019 | $8,712,000 | – | 221,348 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |